EPIX
ESSA Pharma
--
--(--)
Market Open: --
--
--(--)
Post-Market: --
EPIX Profile
Essa Pharma Inc.
A clinical-stage pharmaceutical company that developing novel therapies for the treatment of prostate cancer
Suite 720, 999 West Broadway, Vancouver, BC V5Z 1K5
--
ESSA Pharma Inc., was incorporated under the laws of British Columbia on January 6, 2009. The Company is a development-stage pharmaceutical company focused on the development of small molecule drugs for the treatment of castrated prostate cancer (" CRPC "). The company is developing drugs that selectively block the amino terminal domain (" NTD ") of the androgen receptor (" AR "), which can potentially overcome the known AR-dependent mechanism of CRPC, so that patients with CRPC do not deteriorate and improve survival.